171 related articles for article (PubMed ID: 939693)
1. Protective serum effects in tumor immunity.
Vaage J
Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
[TBL] [Abstract][Full Text] [Related]
2. A time factor in the success or failure of immune rejection of transplanted tumors.
Vaage J
Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
[TBL] [Abstract][Full Text] [Related]
3. Serum therapy for radiation-induced impairment of immune resistance to metastasis.
Vaage J; Agarwal S
Cancer Res; 1977 Oct; 37(10):3556-60. PubMed ID: 908007
[TBL] [Abstract][Full Text] [Related]
4. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
Vaage J; Agarwal S
Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
Vaage J
Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
[No Abstract] [Full Text] [Related]
6. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
BasombrÃo MA; Prehn RT
Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
[No Abstract] [Full Text] [Related]
7. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
Townsend SE; Su FW; Atherton JM; Allison JP
Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
[TBL] [Abstract][Full Text] [Related]
8. Macrophage processing of antigen for induction of tumor immunity.
Brunda MJ; Raffel S
Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
10. Adoptive immunotherapy of a Gross virus producing lymphoma and a methylcholanthrene-induced fibrosarcoma in tolerant rats.
Takeichi N; Kuzumaki N; Kodama T; Kobayashi H; Boone CW
Cancer Res; 1976 Nov; 36(11 Pt 1):4039-43. PubMed ID: 10076
[TBL] [Abstract][Full Text] [Related]
11. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
Martin WJ; Esber E; Cotton WG; Rice JM
J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific immune responsiveness of the tumor-bearing host.
Burk MW; Yu S; McKhann CF
Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to soluble tumor antigens in various stages of tumor growth.
Brannen GE; Santos GW
Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity to progressive tumors can be induced by antigen presented on regressor tumors.
Flood PM; Schreiber H; Ron Y
J Immunol; 1987 May; 138(10):3573-9. PubMed ID: 3571978
[TBL] [Abstract][Full Text] [Related]
15. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
Milas L; Basic I; Kogelnik HD; Withers HR
Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
[TBL] [Abstract][Full Text] [Related]
16. Mammary tumor immune enhancement in mice by local hyperemia.
Vaage J
Cancer Res; 1986 Jan; 46(1):386-9. PubMed ID: 3940204
[TBL] [Abstract][Full Text] [Related]
17. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
20. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
Milas L; Hunter N; Mason K; Withers HR
Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
